Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Long-Term Investments
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
Long-Term Investments
¥9.6B
|
CAGR 3-Years
47%
|
CAGR 5-Years
32%
|
CAGR 10-Years
16%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Long-Term Investments
¥4.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
39%
|
CAGR 10-Years
77%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Long-Term Investments
¥684.7m
|
CAGR 3-Years
189%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Long-Term Investments
¥645.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
2%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Long-Term Investments
¥1.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
72%
|
CAGR 10-Years
76%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Long-Term Investments
¥12.9B
|
CAGR 3-Years
107%
|
CAGR 5-Years
121%
|
CAGR 10-Years
68%
|
See Also
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-Term Investments?
Long-Term Investments
9.6B
CNY
Based on the financial report for Mar 31, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-Term Investments amounts to 9.6B CNY.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
16%
Over the last year, the Long-Term Investments growth was 45%. The average annual Long-Term Investments growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 47% over the past three years , 32% over the past five years , and 16% over the past ten years .